Sekisui House Ltd
SWB:SPH1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sekisui House Ltd
SWB:SPH1
|
JP |
|
P
|
PTC Therapeutics Inc
DUS:BH3
|
US |
Wall St Price Targets
SPH1 Price Targets Summary
Sekisui House Ltd
According to Wall Street analysts, the average 1-year price target for SPH1 is 20.43 EUR with a low forecast of 18.71 EUR and a high forecast of 23.51 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPH1's stock price target?
Price Target
20.43
EUR
According to Wall Street analysts, the average 1-year price target for SPH1 is 20.43 EUR with a low forecast of 18.71 EUR and a high forecast of 23.51 EUR.
What is the Revenue forecast for Sekisui House Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 6%.
What is the Gross Profit forecast for Sekisui House Ltd?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 6%.
What is the Pre-Tax Income forecast for Sekisui House Ltd?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Sekisui House Ltd?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 3 years is 9%.
